期刊
FUTURE ONCOLOGY
卷 19, 期 13, 页码 887-895出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2023-0082
关键词
clinical trial; CD38; daratumumab; dexamethasone; lay summary; lenalidomide; monoclonal antibody; multiple myeloma; newly diagnosed multiple myeloma; plain language summary